Baxter International

Release Summary

Baxter announced that the U.S. FDA has approved FLEXBUMIN [Albumin (Human)], USP, 5% Solution, expanding Baxter’s FLEXBUMIN portfolio to include both 5% and 25% solutions.

Baxter International